Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in France in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
8 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Sep 17 · in 21 days · 3 companies | |||||
| IPHA | Innate Pharma S.A. | Oncology | $253.56M | +28.57% | |
| IDD.DE | Innate Pharma S.A. | Oncology | $243.27M | +12.80% | |
| IPH.PA | Innate Pharma S.A. | Oncology | $240.15M | +19.01% | |
| Monday, Sep 28 · in 32 days · 2 companies | |||||
| OSE.PA | OSE Immunotherapeutics SA | Oncology | $88.75M | −0.19% | |
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| 0RAD.L |
| OSE Immunotherapeutics SA |
| Oncology |
| $51.87M |
| −1.30% |
| Tuesday, Sep 29 · in 33 days · 3 companies | |||||
| NBTX | Nanobiotix S.A. | Oncology | $2.26B | +17.66% | |
| NANO.PA | Nanobiotix S.A. | Oncology | $2.05B | +8.43% | |
| 0QAV.L | Nanobiotix S.A. | Oncology | $671.98M | −1.38% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.